Skip to content

Terodiline

GENITO URINARY SYSTEM AND SEX HORMONES

Also known as: dl-Terodiline, terodiline HCl, terodiline hydrochloride

ATC G04BD05

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Terodiline is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including KCNH2. Recorded indications include Urinary incontinence.

  • Molecular targets: KCNH2 (1 listed in DrugCentral).
  • Indications: Urinary incontinence.
  • ATC code: G04BD05 (Drugs for urinary frequency and incontinence).
  • Molecular formula: C20H27N; molecular weight 281.44 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Urinary incontinence

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Potassium voltage-gated channel subfamily H member 2KCNH2unknownIC50 6.30

ATC classification

ATC codeTherapeutic hierarchy
G04BD05GENITO URINARY SYSTEM AND SEX HORMONES › UROLOGICALS › UROLOGICALS › Drugs for urinary frequency and incontinence

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Terodiline is on its molecule page.

Molecular formulaC20H27N
Molecular weight281.44 g/mol
CAS number15793-40-5
InChIKeyUISARWKNNNHPGI-UHFFFAOYSA-N
PubChem CID23480
CC(CC(C1=CC=CC=C1)C1=CC=CC=C1)NC(C)(C)C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Terodiline used for?

DrugCentral lists the following indications for Terodiline: Urinary incontinence.

How does Terodiline work?

Its molecular targets in DrugCentral include KCNH2.

What is the chemical formula of Terodiline?

Terodiline has the molecular formula C20H27N and a molecular weight of 281.44 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets1
Indications1
FormulaC20H27N
DrugCentral ID2603
Interactive profile